Stock profile

Amplifon S.p.A.(AMP.MI)

Country: ItalySector: HealthcareIndustry: Medical - DistributionExchange: MIL
P/E TTM
39.8
History
P/E NTM
15.2
Market cap
2.38B
Currency EUR
KvantraRanki59
Value81
Quality55
Momentum30
Current price
12.30+1.57%
Benchmarks

No price history available.

Key financial summary

Financials in EUR
202020212022202320242025TTM2026E
Total revenue€m1,5561,9482,1192,2602,4092,396N/AN/A
Operating profit€mLockedLockedLockedLockedLockedLockedLockedLocked
Net profit€m10115817915514591N/AN/A
EPS reportedLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flow€mLockedLockedLockedLockedLockedLockedLockedLocked
Net debt€mLockedLockedLockedLockedLockedLockedLockedLocked
Book value equity€mLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)LockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in EUR
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Amplifon S.p.A. delivers extensive hearing care products and services, empowering individuals to reconnect with the world of sound. Their diverse selection of hearing devices includes models such as ampli-easy, ampli-mini, ampli-connect, and ampli-energy, complemented by personalized fitting services for tailored solutions. As of March 18, 2022, the company maintained a substantial global presence, operating approximately 9,200 retail locations across 25 countries and five continents, further extending its reach through 1,350 franchised outlets. Amplifon conducts operations throughout Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company, established in 1950, is headquartered in Milan, Italy.

SectorHealthcare
IndustryMedical - Distribution
CountryItaly
Trades inEUR

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Amplifon S.p.A. (AMP.MI)

AMP.MI · MIL · Healthcare
12.30+1.57%
Sign up to track this stock

No price history available.

KvantraRank59
P/E TTM39.8
P/E NTM15.2
Market cap2.38B
KvantraRank59 / 100
Value
81
Quality
55
Momentum
30
Financialsin EUR
20242025TTM2026E
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Amplifon S.p.A. delivers extensive hearing care products and services, empowering individuals to reconnect with the world of sound. Their diverse selection of hearing devices includes models such as ampli-easy, ampli-mini, ampli-connect, and ampli-energy, complemented by personalized fitting services for tailored solutions. As of March 18, 2022, the company maintained a substantial global presence, operating approximately 9,200 retail locations across 25 countries and five continents, further extending its reach through 1,350 franchised outlets. Amplifon conducts operations throughout Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company, established in 1950, is headquartered in Milan, Italy.

SectorHealthcare
IndustryMedical - Distribution
CountryItaly
Trades inEUR

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans